Is there value in European equities?

Illuminated office buildings at Canary Wharf, London

(Image credit: Getty Images)

published 9 December 2024

European stocks have struggled this year thanks to the continent’s economic troubles. European equities are now trading at the most significant discount to their US counterparts since at least 2003. The 12-month price-to-earnings (p/e) multiple of the MSCI Eurozone index is 60% of the MSCI US index, compared with its 20-year median of about 80%.

Some of this gap is warranted. Europe has registered anaemic growth since the financial crisis and, since Covid, the economy has ground to a halt. High energy costs and political chaos have hit the core economies.

According to the International Monetary Fund, Europe’s ageing workforce, low productivity growth and “lack of business dynamism” will reduce the continent’s GDP growth rate to just 1.45% per annum over the rest of the decade, compared with 2.3% for the US. JPMorgan estimates that eurozone GDP is expected to fall below 1% next year – without considering the impact of any changes to global trade induced by Donald Trump.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Earnings at listed European companies will stagnate in 2025 for the second year in a row. Tariffs are the wild card. Trump has promised to bring in tariffs on goods imported from Canada, Mexico and China on his first day in office. JPMorgan has put the cost of Trump’s tariffs the first time round (2018) at 1% of euro-area GDP over two years. This time it could amount to as much as 2% if Trump follows through with his plans to hit European imports with tariffs of 10% to 20%. Germany and Italy would be the most vulnerable in this worst-case scenario.

Considering the eurozone’s economic outlook, European equities, in aggregate, deserve to trade at a discount to their US peers. However, uncertainty is creating some opportunities as investors indiscriminately dump European stocks.

Are European equities undervalued?

Europe might not be home to many technology giants but it still offers some of the world’s most successful businesses in their respective fields. The continent’s demographic challenges will also be a tailwind for key sectors. Then there’s the defence sector. Russia’s war against Ukraine has spurred defence spending in Europe, a trend that seems set to continue for many years.

Considering these factors, the iShares MSCI Europe Health Care Sector Ucits exchange-traded fund, or ETF (LSE: ESIH); HANetf’s Future of Defence Ucits ETF (LSE: NATO); and the iShares MSCI Europe Energy Sector Ucits ETF (LSE: ESIE) look worthy of further research. They are regional thematic plays on government spending and the continent’s ageing workforce.

An alternative is JPMorgan’s Europe Research Enhanced Index Equity (ESG) Ucits ETF (LSE: JERE). This ETF builds on the idea of passive index investing by incorporating research from analysts at JPMorgan. It overweights positions to securities with “the highest potential to outperform” while underweighting those considered most overvalued.

The results of this approach have been impressive. Since the fund’s launch in October 2018, it has returned 9.2% annually, compared with 8% for the benchmark (the MSCI Europe Index). The fund is overweight in the UK, at 25.4% of assets compared to 22.6% for the benchmark. It’s also overweight energy names, such as Shell. It’s overweight the Dutch semi-conductor equipment manufacturer ASML but underweight another of the continent’s tech champions, SAP, which gives us a real insight into where the team sees value.

There is no guarantee that Europe’s equity markets will rebound or economic growth will pick up, and the situation could get worse for the region. However, considering the valuation, there’s a lot of potential disappointment already baked in here, and if growth does return, the snap-back could be substantial. With an expense ratio of just 0.25%, it’s a cheap way to build exposure to cheap European markets and avoid some less exciting opportunities.

This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.

Rupert is the former deputy digital editor of MoneyWeek. He's an active investor and has always been fascinated by the world of business and investing. His style has been heavily influenced by US investors Warren Buffett and Philip Carret. He is always looking for high-quality growth opportunities trading at a reasonable price, preferring cash generative businesses with strong balance sheets over blue-sky growth stocks.

Rupert has written for many UK and international publications including the Motley Fool, Gurufocus and ValueWalk, aimed at a range of readers; from the first timers to experienced high-net-worth individuals. Rupert has also founded and managed several businesses, including the New York-based hedge fund newsletter, Hidden Value Stocks. He has written over 20 ebooks and appeared as an expert commentator on the BBC World Service.